ArticlePharmaceuticals (Basel, Switzerland)2022

Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer.

Siva S Panda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.